Literature DB >> 22814510

Tumour immunology: Suppressing the rejection of pancreatic tumours.

Gemma K Alderton.   

Abstract

Entities:  

Year:  2012        PMID： 22814510     DOI： 10.1038/nri3267

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  2 in total

1.  Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

Authors:  Lauren J Bayne; Gregory L Beatty; Nirag Jhala; Carolyn E Clark; Andrew D Rhim; Ben Z Stanger; Robert H Vonderheide
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

2.  Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia.

Authors:  Yuliya Pylayeva-Gupta; Kyoung Eun Lee; Cristina H Hajdu; George Miller; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743
  2 in total
  1 in total

1.  Effect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic function.

Authors:  Francesco Iannone; Alessandra Porzia; Giovanna Peruzzi; Patrizia Birarelli; Bernardina Milana; Luca Sacco; Giuseppe Dinatale; Nadia Peparini; Giampaolo Prezioso; Simone Battella; Roberto Caronna; Stefania Morrone; Gabriella Palmieri; Fabrizio Mainiero; Piero Chirletti
Journal:  Pancreas       Date:  2015-04       Impact factor: 3.327
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.